ASHLEY TYLER: Open Payments
NPI 1063035632 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 52 payments from 17 companies in 2025. Trend: 2023 $3,393 · 2024 $2,794 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $453 |
| ViiV Healthcare Company | 14 | $309 |
| Dendreon Pharmaceuticals LLC | 4 | $84 |
| ABBVIE INC. | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $55 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| Iovance Biotherapeutics, Inc. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $29 |
Products named: Biktarvy, APRETUDE, CABENUVA, PROVENGE, KISQALI, DOVATO, MAVYRET, JEMPERLI.
Industry payments across VA — which companies pay providers there.
